1. Home
  2. Research and Funding
  3. Current Funding Opportunities
  4. Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required)

Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required)

This FOA will support the conduct of clinical trials designed to test the clinical safety and efficacy of artificial pancreas (AP) device systems with the objective of improving glycemic control, reducing acute complications and improving quality of life in people with difficult to control T1D when using standard of care therapies.

Funding Opportunity Details

RFA-DK-19-036
NOT-OD-20-091NOT-OD-20-077NOT-OD-19-128NOT-OD-19-137

Guillermo Arreaza-Rubin, M.D.Thomas Eggerman M.D, PhD.

Key Dates

3/9/2020

March 09, 2020

April 09, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.